TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
QURE

Uniqure NV

Healthcare · Biotechnology

39.10$ +2.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Uniqure NV (QURE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 16 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement QURE
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
5.7 10 25 13 11 7.3 38 524 106 16 27 16
44 0.6 73 67 73 95 122 25 3.3 14 18 1.7
-38 9.7 25 -54 -62 7.3 -85 499 103 2.2 8.8 14
41 51 73 72 75 95 122 144 198 215 144 141
17 23 25 25 25 34 43 57 55 73 51 65
47 72 97 85 100 128 41 188 246 285 193 202
-41 -75 -72 -72 -88 -121 -125 311 -143 -283 -184 -188
2.0 2.6 2.2 2.5 2.2 3.8 3.8 7.5 12 42 64 62
-45 -79 -72 -81 -83 -124 -141 333 -128 -307 -237 -193
4.2 0.5 1.1 -0.2 0.2 3.8 -16 3.2 -1.5 1.9 2.4 5.6
-45 -78 -73 -80 -83 -124 -125 330 -127 -308 -240 -199
-46 -72 -66 -70 -74 -114 -127 319 -108 -253 -161 -117

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?